Thank you for visiting our website.
Until further notice, Tradeo is no longer accepting new clients.
It’s a busy day ahead on the economic calendar. Service sector PMIs and U.S jobless claims will be in focus. Brexit and COVID-19 remain key drivers, however.
For the EUR
It’s a busy day ahead on the economic calendar. Spanish and Italian service sector PMI numbers are due out along with Eurozone retail sales figures for October. Finalized services and composite PMI figures are also due out of France, Germany, and the Eurozone.
Barring any marked revisions to prelim figures, we would expect Italy and the Eurozone’s PMIs to garner the greatest interest.
Away from the economic calendar, Brexit updates will also provide direction.
At the time of writing, the EUR was down by 0.02% to $1.2113.
For the Pound
It’s a relatively quiet day ahead on the economic calendar. Finalized services and composite PMI figures are due out later today.
Barring material revisions to prelim figures the stats are unlikely to have a material impact on the Pound.
Expect Brexit updates to be the key driver on the day.
At the time of writing, the Pound was up by 0.01% to $1.3366.
For The USD
It’s a relatively busy day ahead for the U.S Dollar. November’s ISM Non-Manufacturing PMI and weekly jobless claims figures will have the greatest influence on market risk sentiment.
Markit services and composite PMI numbers will likely have a muted impact on the day.
Away from the economic calendar, any chatter from Capitol Hill and COVID-19 news updates will continue to influence.
At the time of writing, the Dollar Spot Index was down by 0.08% to 91.041.
GBP/USD did not manage to settle below the support at 1.3300 and rebounded towards the nearest resistance level at 1.3400.
GBP/USD failed to settle below the support at 1.3300 and rebounded closer to the resistance at 1.3400. In case GBP/USD manages to settle above the resistance at 1.3400, it will gain upside momentum and head towards the next resistance level which has recently emerged at 1.3440.
A successful test of the resistance at 1.3440 will push GBP/USD towards the next resistance level at September highs at 1.3485.
On the support side, the nearest support level for GBP/USD is located at 1.3325. There are no important levels between 1.3325 and 1.3400 so GBP/USD easily moves back and forth between these levels.
If GBP/USD gets below the support at 1.3325, it will get to another test of the next support at 1.3300. A move below the support at 1.3300 will open the way to the test of the support at 1.3270.
According to flash data for gold futures markets from CME Group, open interest rose by more than 5K contracts on Wednesday after two consecutive daily drops. On the other hand, volume extended the downtrend and shrunk by around 15.6K contracts.
Gold now looks to $1,850/oz
Prices of the ounce troy of gold edged higher on Wednesday, extending the bounce off monthly lows near $1,760 (November 30) amidst increasing open interest. That said, the yellow metal now targets the mid-$1,800s, or September’s lows. This area is reinforced by the proximity of the 21-day SMA ($1,854).
Pfizer and Moderna apply for EU vaccine approval
US stocks started the last month of the year on a positive note, with the Nasdaq hitting an all-time high. All sectors in the S&P 500 index were higher, led by financials, industrials were the worst-performing sector in the S&P 500 index. Pfizer and Moderna on Tuesday applied for vaccine approval in the EU. The Nasdaq announced that it would require in the future that all companies listed had at least one woman and one minority on the board of directors. US ISM Manufacturing came in softer than expected with a dip into contraction territory for employment. The dollar continued to tumble hitting a 2.5-year low.
Pfizer and Moderna Apply for Vaccine Approval in the EU
Pfizer Inc. and U.S. drugmaker Moderna Inc. both applied for their coronavirus vaccines to be approved in the European Union. The announcement brings hope that the EU will soon be able to start vaccinating its 448 million people against a disease
Legal disclaimer: The material does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instruments. UR Trade Fix Ltd accepts no responsibility for any use that may be made of these comments and for any consequences resulting in it. No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. The analysis does not involve any specific investment objectives, financial situation and needs of any specific person who may receive it. Past performance does not constitute a reliable indicator of future results and future forecasts do not constitute a reliable indicator of future performance.
It has not been prepared in accordance with legal requirements designed to promote the independence of research, and as such it is considered to be marketing communication. Although we are not specifically constrained from dealing ahead of the publication of our research, we do not seek to take advantage of it before we provide it to our clients. We aim to establish, maintain and operate effective organizational and administrative arrangements with a view to taking all reasonable steps to prevent conflicts of interest from constituting or giving rise to a material risk of damage to the interests of our clients. We operate a policy of independence, which requires our employees to act in our clients’ best interests when providing our services.